A New Era in High-Throughput Flow Cytometry In today’s fast-paced drug discovery and screening environments, speed, prec | ...
The US Patent and Trademark Office will issue BIAF a new patent on its flow cytometry+AI platform that detects lung cancer as ...
The global sepsis diagnostics market, valued at USD 835.40 million in 2023, is projected to reach USD 1.39 billion by 2029, driven by advancements in healthcare infrastructure and awareness of sepsis, ...
Affinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.
DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.
BostonGene’s Foundation Model of Cancer and the Immune System–Led Approach Recognized for Advancing Precision Oncology and De-Risking Drug Development for BiopharmaWALTHAM, Mass.--(BUSINESS ...
Novate’s BactoSense analysers are giving scientists live insight into Mount Fuji’s vast volcanic aquifer, helping secure safe ...
SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today ...
Researchers at the Medical University of Vienna have uncovered how a little-studied protein, TRAT1 (T Cell Receptor ...
A defined, xeno-free culture medium from Takara Bio Europe is opening new possibilities for large-scale production of ...
D cell cultures are no longer a futuristic idea. They’re already reshaping how we study diseases like cancer, offering more ...
A new Galleri blood test detected 75% of cancers without current screening options, with over half found in early stage I or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results